<DOC>
	<DOCNO>NCT00418535</DOCNO>
	<brief_summary>Nasal NK/T-cell lymphoma peculiar clinico-pathologic subtype non-Hodgkin 's lymphoma ( NHL ) . Although patient present stage I/II , 30-60 % patient remain disease-free . The efficacy conventional anthracycline-based chemotherapy ( cyclophosphamide , doxorubicin , vincristine , prednisone [ CHOPP ] ) unsatisfactory . The optimal treatment localize NK/T-cell lymphoma define yet . The optimal dose , sequence , multi-modality treatment involve field radiotherapy still need refine . This trial evaluate efficacy concurrent chemoradiotherapy cisplatin follow VIPD ( etoposide , ifosfamide , cisplatin , dexamethasone ) localize NK/T-cell lymphoma patient .</brief_summary>
	<brief_title>Clinical Study Chemoradiation Followed VIPD Nasal Natural Killer ( NK ) /T-cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Pathologically confirm NK/Tcell lymphoma Localized ( Ann Arbor stage I/II ) disease At least one measurable lesion Age &gt; 18 ECOG performance status 0 2 Expected life span least 12 week Normal marrow function ( hemoglobin ≥ 9.0 g/dL ; absolute neutrophil count ≥ 1,500/mm3 ; platelet count ≥ 100,000/mm3 ) Normal liver function ( total bilirubin &lt; 2x upper limit normal [ ULN ] , transaminase &lt; 3x ULN ) Normal renal function ( serum creatinine ≤ 1.5 mg/dL , creatinine clearance ≥ 50 mL/min ) Written inform consent Other malignancy except treated nonmelanoma skin cancer cervical cancer situ Serious medical illness ( congestive heart failure , angina , respiratory failure , renal failure ) Acute active infection require intravenous ( IV ) antibiotic Pregnant , lactate woman Previous history chemotherapy radiotherapy Concomitant medication may influence study drug Allergic reaction study drug Grade 2 great peripheral neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Lymphoma , NK/T-Cell</keyword>
</DOC>